BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32158512)

  • 1. Detection of immunoglobulin G levels produced by oral polio vaccine in HIV infected children in Jos, Plateau State, Nigeria.
    Lengkat FA; Chukwudozie OS; Vincent OO; James DM; Amina HG; Kenneth O
    Pan Afr Med J; 2019; 34():183. PubMed ID: 32158512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic response to oral polio vaccine in human immunodeficiency virus-infected and uninfected Zimbabwean children.
    Gnanashanmugam D; Troy SB; Musingwini G; Huang C; Halpern MS; Stranix-Chibanda L; Shetty AK; Kouiavskaia D; Nathoo K; Chumakov K; Maldonado YA
    Pediatr Infect Dis J; 2012 Feb; 31(2):176-80. PubMed ID: 22146742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Dedicated Mobile Teams and Polio Volunteer Community Mobilizers to Increase Access to Zero-Dose Oral Poliovirus Vaccine and Routine Childhood Immunizations in Settlements at High Risk for Polio Transmission in Northern Nigeria.
    Ongwae KM; Bawa SB; Shuaib F; Braka F; Corkum M; Isa HK
    J Infect Dis; 2017 Jul; 216(suppl_1):S267-S272. PubMed ID: 28838155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress toward poliomyelitis eradication in Nigeria.
    Ado JM; Etsano A; Shuaib F; Damisa E; Mkanda P; Gasasira A; Banda R; Korir C; Johnson T; Dieng B; Corkum M; Enemaku O; Mataruse N; Ohuabunwo C; Baig S; Galway M; Seaman V; Wiesen E; Vertefeuille J; Ogbuanu IU; Armstrong G; Mahoney FJ
    J Infect Dis; 2014 Nov; 210 Suppl 1(Suppl 1):S40-9. PubMed ID: 25316862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralizing anti-polio antibody titre in newborn babies in post-polio eradication period in Nigeria.
    Ughasoro MD; Nnakenyi I; Echendu N; Akpeh JO; Oji-Onuoha S; Anyaoha U; Mbanefo N; Ofodile K
    Vaccine; 2023 Nov; 41(46):6820-6823. PubMed ID: 37806806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis.
    Ciapponi A; Bardach A; Rey Ares L; Glujovsky D; Cafferata ML; Cesaroni S; Bhatti A
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011260. PubMed ID: 31801180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress toward poliomyelitis eradication--Nigeria, 2005-2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Mar; 56(12):278-81. PubMed ID: 17392680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the prevalence of antibody immunodeficiency in a polio endemic area in India.
    Mohanty MC; Deshpande JM
    Trans R Soc Trop Med Hyg; 2014 May; 108(5):258-63. PubMed ID: 24652773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1997 Jan; 46(RR-3):1-25. PubMed ID: 9026708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral polio vaccine response in the MAL-ED birth cohort study: Considerations for polio eradication strategies.
    Pan WK; Seidman JC; Ali A; Hoest C; Mason C; Mondal D; Knobler SL; Bessong P;
    Vaccine; 2019 Jan; 37(2):352-365. PubMed ID: 30442479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population Immunity against Serotype-2 Poliomyelitis Leading up to the Global Withdrawal of the Oral Poliovirus Vaccine: Spatio-temporal Modelling of Surveillance Data.
    Pons-Salort M; Molodecky NA; O'Reilly KM; Wadood MZ; Safdar RM; Etsano A; Vaz RG; Jafari H; Grassly NC; Blake IM
    PLoS Med; 2016 Oct; 13(10):e1002140. PubMed ID: 27701425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Micro-planning for immunization in Kaduna State, Nigeria: Lessons learnt, 2017.
    Umeh GC; Madubu DM; Korir C; Loveday N; Ishaku S; Iyal H; Omoleke SA; I Nomhwange T; Aliyu A; Musa A; Dankoli R; Mi Ningi A; Braka F; Dogo PM; Soba H; Iliyasu N
    Vaccine; 2018 Nov; 36(48):7361-7368. PubMed ID: 30366806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experiences from polio supplementary immunization activities in Anambra State, Nigeria.
    Onyeka IN; Ilika AL; Ilika FN; Umeh DC; Onyibe RI; Okoye CJ; Diden G; Onubogu CU
    Niger J Clin Pract; 2014; 17(6):808-13. PubMed ID: 25385924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine poliovirus shedding and immune response to oral polio vaccine in HIV-infected and -uninfected Zimbabwean infants.
    Troy SB; Musingwini G; Halpern MS; Huang C; Stranix-Chibanda L; Kouiavskaia D; Shetty AK; Chumakov K; Nathoo K; Maldonado YA
    J Infect Dis; 2013 Aug; 208(4):672-8. PubMed ID: 23661792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinations of Quality and Frequency of Immunization Activities to Stop and Prevent Poliovirus Transmission in the High-Risk Area of Northwest Nigeria.
    Duintjer Tebbens RJ; Pallansch MA; Wassilak SG; Cochi SL; Thompson KM
    PLoS One; 2015; 10(6):e0130123. PubMed ID: 26068928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Polio vaccines, eradication and posterradication].
    Salmerón García F; Portela Moreira A; Soler Soneira M; López Hernández S; Chamorro Somoza Díaz-Sarmiento M; Pérez González I; Rubio Gómez MI; Pérez González A; Sagredo Rodríguez A; Ruiz Antúnez S; Timón Jiménez M; Frutos Cabanillas G
    Rev Esp Salud Publica; 2013; 87(5):497-505. PubMed ID: 24322286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eradicating polio: how the world's pediatricians can help stop this crippling illness forever.
    Orenstein WA;
    Pediatrics; 2015 Jan; 135(1):196-202. PubMed ID: 25548328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wild and vaccine-derived poliovirus circulation, and implications for polio eradication.
    Lopalco PL
    Epidemiol Infect; 2017 Feb; 145(3):413-419. PubMed ID: 27866483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Budget impact of polio immunization strategy for India: introduction of one dose of inactivated poliomyelitis vaccine and reductions in supplemental polio immunization.
    Khan MM; Sharma S; Tripathi B; Alvarez FP
    Public Health; 2017 Jan; 142():31-38. PubMed ID: 28057194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polio eradication: the OPV paradox.
    Dowdle WR; De Gourville E; Kew OM; Pallansch MA; Wood DJ
    Rev Med Virol; 2003; 13(5):277-91. PubMed ID: 12931339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.